Compare TTGT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTGT | LAB |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | United States |
| Employees | N/A | 389 |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.6M | 257.2M |
| IPO Year | 2024 | 2008 |
| Metric | TTGT | LAB |
|---|---|---|
| Price | $2.81 | $0.72 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 430.7K | ★ 758.9K |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $0.69 | N/A |
| Revenue Next Year | $2.42 | N/A |
| P/E Ratio | ★ N/A | $2.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.45 | $0.59 |
| 52 Week High | $6.70 | $1.72 |
| Indicator | TTGT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 34.58 | 62.71 |
| Support Level | N/A | $0.71 |
| Resistance Level | $4.09 | $0.79 |
| Average True Range (ATR) | 0.28 | 0.04 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 24.33 | 90.33 |
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.